Cancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.

by Kevin McLaughlin

Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.

Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.

by Kyle Bagenstose

Mammography screening recommendation pushed back to age 40, and pancreatic cancer vaccine shows promising immune response.

by Marci A. Landsmann

An increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.

by Sandra Gordon

AACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.

by Thomas Celona

Researchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach for patients with HIV.

by Thomas Celona

An expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.

by Eric Fitzsimmons

More programs address sexual health in cancer survivors, and survey suggests health insurance often doesn’t cover genetic tumor testing.

by Marci A. Landsmann

People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.

by Marci A. Landsmann